New user? Sign up here |

Considerations When Prescribing PrEP & nPEP

Details

Starts at: January 15, 2025 4:30pm ET
Ends at: January 15, 2025 5:30pm ET
Free Admission

Invite Only: Password Protected

Description

This training will highlight key considerations when prescribing HIV pre-exposure prophylaxis (PrEP) and post exposure prophylaxis (PEP) in a clinical setting. 

Learning objectives:

  • Identify individuals who may benefit from PrEP using the status neutral approach. 
  • Understand how to counsel patients about PrEP, evaluate their suitability, and monitor their progress while on PrEP.
  • Discuss CDC’s recommended PrEP regimens, including dosing, safety, testing, initiation, follow-up assessments, and side effects.

Intended Audience

ChristianaCare Ob-GYN clinicians

Contact

Person: Danielle C Johnson
Email: danielle.johnson@christianacare.org

Materials

Topics

A variety of the listed topics will be discussed at this event.

  • Post-exposure Prophylaxis (PEP, occupational and non-occupational)
  • Pre-exposure prophylaxis (PrEP)
  • Sexual Health History Taking
  • HIV diagnosis (i.e. HIV testing)
  • HIV monitoring and lab tests (i.e. CD4 ad viral load)